CAS: 1370651-20-9; 6-Amino-5-((R)-1-(2,6-Dichloro-3-Fluorophenyl)Ethoxy)-N-(4-((3R,5S)-3,5-Dimethylpiperazine-1-Carbonyl)Phenyl)Pyridazine-3-Carboxamide

结构式图片

合成工艺路线路线简述

    📜以24.6的收率获得爱沙替尼
    参考文献:Substituted Pyridazine Carboxamide Compounds
    标题:Substituted Pyridazine Carboxamide Compounds
    摘要:新的吡啶嗪衍生物具有意想不到的药物特性,作为蛋白激酶抑制剂,尤其对alk具有作用,并且在治疗与异常蛋白激酶活性相关的疾病,如癌症,神经和精神疾病方面是有用的.

    海关参考信息

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Insights into ALK-driven cancers revealed through development of novel ALK tyrosine kinase inhibitors Christine M. Lovly, Johannes M. Heuckmann, Elisa de Stanchina, Heidi Chen, Roman K. Thomas, Chris Liang, William Pao Cancer Res. Author manuscript; available in PMC 2012 July 15.Published in final edited form as: Cancer Res. 2011 July 15; 71(14): 4920–4931. Published online 2011 May 25. doi: 10.1158/0008-5472.CAN-10-3879 Palmer F1000 Med Rep. 2011;
    3: 21. Published online 2011 November 1. doi: 10.3410/M3-21 2014;
    4: 174. Prepublished online 2014 June 6. Published online 2014 July 21. doi: 10.3389/fonc.2014.00174 2012;
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知